Moody’s also affirmed the “Baa2” rating on the medical center’s $363 million of rated debt.
The ratings assignment and affirmation is based on several factors, including EMC’s good market position and solid cash flow.
The outlook is stable, reflecting Moody’s Investors Service’s expectation EMC will continue to generate favorable margins, but that its capital spending will limit balance sheet growth during the next two years.
More articles on healthcare finance:
Moody’s affirms ‘Baa2’ rating on Bethesda Health’s bonds
Moody’s affirms ‘Baa2’ rating on Exeter Hospital’s bonds
Moody’s affirms ‘A2′ rating on University Hospitals’ bonds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
